Z

ZimVie Inc
NASDAQ:ZIMV

Watchlist Manager
ZimVie Inc
NASDAQ:ZIMV
Watchlist
Price: 14.17 USD 3.13% Market Closed
Market Cap: 391.1m USD
Have any thoughts about
ZimVie Inc?
Write Note

ZimVie Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ZimVie Inc
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Z
ZimVie Inc
NASDAQ:ZIMV
Capital Expenditures
-$12.5m
CAGR 3-Years
31%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Capital Expenditures
-$725m
CAGR 3-Years
15%
CAGR 5-Years
5%
CAGR 10-Years
-1%
Boston Scientific Corp
NYSE:BSX
Capital Expenditures
-$780m
CAGR 3-Years
-15%
CAGR 5-Years
-8%
CAGR 10-Years
-10%
Stryker Corp
NYSE:SYK
Capital Expenditures
-$634m
CAGR 3-Years
-9%
CAGR 5-Years
-1%
CAGR 10-Years
-11%
Abbott Laboratories
NYSE:ABT
Capital Expenditures
-$2.2B
CAGR 3-Years
-5%
CAGR 5-Years
-6%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Capital Expenditures
-$1.2B
CAGR 3-Years
-67%
CAGR 5-Years
-29%
CAGR 10-Years
-33%
No Stocks Found

ZimVie Inc
Glance View

Market Cap
390.9m USD
Industry
Health Care

Zimvie, Inc. operates as a holding company, which engages in the manufacture, design, and distribution of medical devices and surgical instruments. The company is headquartered in Westminster, Colorado and currently employs 2,700 full-time employees. The company went IPO on 2022-02-14. The firm develops, manufactures, and markets a portfolio of products and solutions designed to treat a range of spine pathologies and support dental tooth replacement and restoration procedures. The Company’s operations are managed on a products basis and include two operating segments: the spine products segment, and the dental products segment. Its spine products segment focused on designing, manufacturing, and distributing medical devices and surgical instruments to deliver solutions for individuals with back or neck pain caused by degenerative conditions, deformities, tumors, or traumatic injury of the spine. Its product portfolio includes Mobi-C Cervical Disc and the Tether device. Its dental products segment is focused on designing, manufacturing and/or distributing of dental implant solutions. Its products include T3 Implant, Tapered Screw-Vent Implant System, Trabecular Metal Dental Implant, and BellaTek Encode Impression System.

ZIMV Intrinsic Value
17.8 USD
Undervaluation 20%
Intrinsic Value
Price
Z

See Also

What is ZimVie Inc's Capital Expenditures?
Capital Expenditures
-12.5m USD

Based on the financial report for Dec 31, 2023, ZimVie Inc's Capital Expenditures amounts to -12.5m USD.

What is ZimVie Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
24%

Over the last year, the Capital Expenditures growth was 53%. The average annual Capital Expenditures growth rates for ZimVie Inc have been 31% over the past three years , 24% over the past five years .

Back to Top